All of our patient's symptoms were typical of ethanol and benzodiazepine withdrawal syndromes. The patient received several doses of lorazepam, with no subsequent improvement in any of her symptoms.

Objective: To evaluate literature reporting on the role of norepinephrine in alcohol withdrawal and to determine the safety and efficacy of α 2-agonists in reducing symptoms of this severe condition.

valentinrussanov / Getty Images A systematic withdrawal plan (SWP) allows for pre-planned cash flows generated by investments as income in retirement. A systematic withdrawal plan (SWP ...

Depression, a common mental disorder that involves a depressed mood or loss of pleasure or interest in activities for long periods of time, is often difficult for an individual experiencing it, and ...

Symptoms of diabetes commonly include increased thirst, blurred vision, frequent urination, and fatigue. Learn more about how symptoms may differ between type 1 and type 2 diabetes. Diabetes ...

UCB, a global biopharmaceutical company, today announced it will present 24 abstracts from its expansive neurology portfolio, regarding rare epilepsies Dravet syndrome (DS) and Lennox-Gastaut syndrome ...

Watch: ‘Survivor’ contestant jumps into action to help co-competitor with autism ...

Where algorithmic advice is given, this advice might not be sufficiently specific. A 2022 review highlighted these shortcomings, and also noted inadequate guidance on maintenance treatment duration ...